{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:06:35Z","timestamp":1790687195341,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["EY028858"],"award-info":[{"award-number":["EY028858"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["P30 EY02172"],"award-info":[{"award-number":["P30 EY02172"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY028858"],"award-info":[{"award-number":["EY028858"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY021752"],"award-info":[{"award-number":["EY021752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY024564"],"award-info":[{"award-number":["EY024564"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL102033"],"award-info":[{"award-number":["HL102033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.omtm.2019.06.007","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T19:27:48Z","timestamp":1562786868000},"page":"161-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice"],"prefix":"10.1016","volume":"14","author":[{"given":"Amrisha","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengquan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juantao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan K.","family":"Raizada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.06.007_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtm.2019.06.007_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.omtm.2019.06.007_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00109-008-0336-0","article-title":"Update on tissue renin-angiotensin systems","volume":"86","author":"Bader","year":"2008","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.omtm.2019.06.007_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11906-012-0323-2","article-title":"The renin angiotensin aldosterone system and insulin resistance in humans","volume":"15","author":"Underwood","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.omtm.2019.06.007_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1515\/jtim-2016-0022","article-title":"Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome","volume":"4","author":"Das","year":"2016","journal-title":"J.\u00a0Transl. Int. Med."},{"key":"10.1016\/j.omtm.2019.06.007_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mcna.2016.08.009","article-title":"The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome","volume":"101","author":"Cabandugama","year":"2017","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.omtm.2019.06.007_bib7","first-page":"8917578","article-title":"Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.omtm.2019.06.007_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.omtm.2019.06.007_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000342776","article-title":"The renin-angiotensin system in the pathophysiology of type 2 diabetes","volume":"5","author":"Goossens","year":"2012","journal-title":"Obes. Facts"},{"key":"10.1016\/j.omtm.2019.06.007_bib10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbadis.2016.07.019","article-title":"The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance","volume":"1863","author":"Ramalingam","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.omtm.2019.06.007_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","article-title":"The renin-angiotensin system: a link between obesity, inflammation and insulin resistance","volume":"13","author":"Kalupahana","year":"2012","journal-title":"Obes. Rev."},{"key":"10.1016\/j.omtm.2019.06.007_bib12","doi-asserted-by":"crossref","first-page":"e1001971","DOI":"10.1371\/journal.pmed.1001971","article-title":"Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses","volume":"13","author":"Catal\u00e1-L\u00f3pez","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.omtm.2019.06.007_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1742-1241.2010.02552.x","article-title":"Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review","volume":"65","author":"Sj\u00f8lie","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.omtm.2019.06.007_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1742-1241.2010.02592.x","article-title":"Renin-angiotensin blockade in diabetic retinopathy","volume":"65","author":"Ghattas","year":"2011","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.omtm.2019.06.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/eye.2009.189","article-title":"Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme","volume":"24","author":"Wright","year":"2010","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.omtm.2019.06.007_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJMe0904293","article-title":"Diabetes complications and the renin-angiotensin system","volume":"361","author":"Perkins","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2019.06.007_bib17","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.diabres.2007.01.015","article-title":"Prospects for angiotensin receptor blockers in diabetic retinopathy","volume":"76","author":"Sj\u00f8lie","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.omtm.2019.06.007_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/02713683.2013.772206","article-title":"The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy","volume":"38","author":"Byon","year":"2013","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.omtm.2019.06.007_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jdi.12028","article-title":"Angiotensin-converting enzyme gene variants interact with the renin-angiotensin system pathway to confer risk and protection against type 2 diabetic retinopathy","volume":"4","author":"Cheema","year":"2013","journal-title":"J.\u00a0Diabetes Investig."},{"key":"10.1016\/j.omtm.2019.06.007_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.preteyeres.2010.03.003","article-title":"The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature","volume":"29","author":"Fletcher","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2019.06.007_bib21","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/dc11-0476","article-title":"Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control","volume":"34","author":"Harindhanavudhi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.omtm.2019.06.007_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1574884711308040004","article-title":"The renin-angiotensin system and advanced glycation end-products in diabetic retinopathy: impacts and synergies","volume":"8","author":"Miller","year":"2013","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.omtm.2019.06.007_bib23","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1167\/iovs.16-20289","article-title":"Beneficial Effects of Combined AT1 Receptor\/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye","volume":"57","author":"Prasad","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.06.007_bib24","doi-asserted-by":"crossref","first-page":"e100954","DOI":"10.1371\/journal.pone.0100954","article-title":"Combined renin inhibition\/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats","volume":"9","author":"Batenburg","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.06.007_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/138920111794480615","article-title":"The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy","volume":"12","author":"Jeganathan","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.omtm.2019.06.007_bib26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.biocel.2005.08.002","article-title":"Angiotensin and diabetic retinopathy","volume":"38","author":"Wilkinson-Berka","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.omtm.2019.06.007_bib27","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtm.2019.06.007_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.06.007_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.peptides.2014.07.002","article-title":"Angiotensin 1-7: a peptide for preventing and treating metabolic syndrome","volume":"59","author":"Santos","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.omtm.2019.06.007_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/CS20130344","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications","volume":"126","author":"Patel","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.omtm.2019.06.007_bib31","first-page":"6","article-title":"Angiotensin-(1-7): A\u00a0Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?","volume":"6","author":"Padda","year":"2015","journal-title":"J.\u00a0Diabetes Metab."},{"key":"10.1016\/j.omtm.2019.06.007_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2174\/0929866524666170728144357","article-title":"Renin-Angiotensin System in Diabetes","volume":"24","author":"Rein","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.omtm.2019.06.007_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtm.2019.06.007_bib34","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1167\/iovs.14-13883","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice","volume":"55","author":"Qiu","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.06.007_bib35","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/mt.2014.179","article-title":"Oral delivery of ACE2\/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis","volume":"22","author":"Shil","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.06.007_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy","volume":"20","author":"Verma","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.06.007_bib37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.ajpath.2016.01.023","article-title":"Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice","volume":"186","author":"Dominguez","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2019.06.007_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/17425247.2.1.29","article-title":"Commercial challenges of protein drug delivery","volume":"2","author":"Brown","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.omtm.2019.06.007_bib39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2174\/1389450117666151209120139","article-title":"Delivery of Therapeutic Proteins: Challenges and Strategies","volume":"17","author":"Rehman","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.omtm.2019.06.007_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1208\/s12248-012-9340-y","article-title":"Immunogenicity to therapeutic proteins: impact on PK\/PD and efficacy","volume":"14","author":"Chirmule","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.omtm.2019.06.007_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diabet.2016.04.004","article-title":"Impact of gut microbiota on diabetes mellitus","volume":"42","author":"Blandino","year":"2016","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.omtm.2019.06.007_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/dc14-0769","article-title":"Insights into the role of the microbiome in obesity and type 2 diabetes","volume":"38","author":"Hartstra","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.omtm.2019.06.007_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11892-016-0781-z","article-title":"The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis","volume":"16","author":"Needell","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.omtm.2019.06.007_bib44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/nutrit\/nuw039","article-title":"Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis","volume":"74","author":"Akbari","year":"2016","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.omtm.2019.06.007_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.diabres.2016.06.014","article-title":"Probiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"118","author":"Samah","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.omtm.2019.06.007_bib46","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.3390\/ijms17060928","article-title":"Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials","volume":"17","author":"S\u00e1ez-Lara","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2019.06.007_bib47","doi-asserted-by":"crossref","first-page":"e4088","DOI":"10.1097\/MD.0000000000004088","article-title":"Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: A meta-analysis of randomized, controlled trials","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.omtm.2019.06.007_bib48","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S0007114516000076","article-title":"Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials","volume":"115","author":"Sun","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.omtm.2019.06.007_bib49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.medici.2015.11.008","article-title":"Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials","volume":"52","author":"Zhang","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.omtm.2019.06.007_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/dmrr.2665","article-title":"Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review","volume":"32","author":"Razmpoosh","year":"2016","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.omtm.2019.06.007_bib51","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.micinf.2013.08.003","article-title":"ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition","volume":"15","author":"Perlot","year":"2013","journal-title":"Microbes Infect."},{"key":"10.1016\/j.omtm.2019.06.007_bib52","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/FJC.0000000000000307","article-title":"ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy","volume":"66","author":"Cole-Jeffrey","year":"2015","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.omtm.2019.06.007_bib53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.copbio.2017.08.004","article-title":"Intestinal Lactobacillus in health and disease, a driver or just along for the ride?","volume":"49","author":"Heeney","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.omtm.2019.06.007_bib54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/MMBR.00017-08","article-title":"Genes and molecules of lactobacilli supporting probiotic action","volume":"72","author":"Lebeer","year":"2008","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.omtm.2019.06.007_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/jclinpath-2015-202976","article-title":"Mechanisms and therapeutic effectiveness of lactobacilli","volume":"69","author":"Di Cerbo","year":"2016","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.omtm.2019.06.007_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAD-0011-2016","article-title":"The Genomic Basis of Lactobacilli as Health-Promoting Organisms","volume":"5","author":"Salvetti","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.omtm.2019.06.007_bib57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.mib.2013.06.002","article-title":"Engineering lactococci and lactobacilli for human health","volume":"16","author":"Berm\u00fadez-Humar\u00e1n","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.omtm.2019.06.007_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12934-015-0313-6","article-title":"Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes","volume":"14","author":"Cano-Garrido","year":"2015","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.omtm.2019.06.007_bib59","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00253-019-09628-y","article-title":"Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides","volume":"103","author":"Plavec","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.omtm.2019.06.007_bib60","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/nar\/22.6.929","article-title":"Divergence in codon usage of Lactobacillus species","volume":"22","author":"Pouwels","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2019.06.007_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1574-6968.2010.01978.x","article-title":"Comparison of expression vectors in Lactobacillus reuteri strains","volume":"308","author":"Lizier","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.omtm.2019.06.007_bib62","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4014\/jmb.0907.07032","article-title":"Development of a highly efficient protein-secreting system in recombinant Lactobacillus casei","volume":"20","author":"Kajikawa","year":"2010","journal-title":"J.\u00a0Microbiol. Biotechnol."},{"key":"10.1016\/j.omtm.2019.06.007_bib63","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1167\/iovs.09-5147","article-title":"Diabetic eNOS-knockout mice develop accelerated retinopathy","volume":"51","author":"Li","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.06.007_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI4431","article-title":"A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse","volume":"103","author":"Wang","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2019.06.007_bib65","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1167\/iovs.04-1340","article-title":"The Ins2Akita mouse as a model of early retinal complications in diabetes","volume":"46","author":"Barber","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.06.007_bib66","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2019.06.007_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1871530314666141216121349","article-title":"Role of probiotics and functional foods in health: gut immune stimulation by two probiotic strains and a potential probiotic yoghurt","volume":"15","author":"Maldonado Galdeano","year":"2015","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.omtm.2019.06.007_bib68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.disamonth.2015.03.011","article-title":"Probiotics","volume":"61","author":"Mizock","year":"2015","journal-title":"Dis. Mon."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2019.06.007_bib69","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0000000000000350","article-title":"Probiotics in 2015: Their Scope and Use","volume":"49","author":"Sanders","year":"2015","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.omtm.2019.06.007_bib70","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.2337\/diacare.27.10.2568","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Rathmann","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.omtm.2019.06.007_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MED.0b013e328350583a","article-title":"The worldwide diabetes epidemic","volume":"19","author":"Lam","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.omtm.2019.06.007_bib72","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.omtm.2019.06.007_bib73","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2019.06.007_bib74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.06.007_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09286580701396720","article-title":"Overview of epidemiologic studies of diabetic retinopathy","volume":"14","author":"Klein","year":"2007","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.omtm.2019.06.007_bib76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.omtm.2019.06.007_bib77","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.omtm.2019.06.007_bib78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4239\/wjd.v6.i3.489","article-title":"Diabetic retinopathy - ocular complications of diabetes mellitus","volume":"6","author":"Nentwich","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.omtm.2019.06.007_bib79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/pedi.12424","article-title":"Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome","volume":"17","author":"Paun","year":"2016","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.omtm.2019.06.007_bib80","doi-asserted-by":"crossref","first-page":"17737","DOI":"10.3748\/wjg.v20.i47.17737","article-title":"Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective","volume":"20","author":"Han","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omtm.2019.06.007_bib81","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11892-013-0409-5","article-title":"Human intestinal microbiota and type 1 diabetes","volume":"13","author":"Vaarala","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.omtm.2019.06.007_bib82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MED.0b013e3283628569","article-title":"The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes","volume":"20","author":"Zipris","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.omtm.2019.06.007_bib83","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.2174\/1381612822666160922165706","article-title":"Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes","volume":"22","author":"Slyepchenko","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omtm.2019.06.007_bib84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/07853890.2016.1222449","article-title":"Is there a role for gut microbiota in type 1 diabetes pathogenesis?","volume":"49","author":"Bibb\u00f2","year":"2017","journal-title":"Ann. Med."},{"key":"10.1016\/j.omtm.2019.06.007_bib85","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.trsl.2016.09.001","article-title":"Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes","volume":"179","author":"Scott","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.omtm.2019.06.007_bib86","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.02.004","article-title":"Immune recognition and response to the intestinal microbiome in type 1 diabetes","volume":"71","author":"Paun","year":"2016","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.omtm.2019.06.007_bib87","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4049\/jimmunol.1601519","article-title":"The Influence of the Microbiome on Type 1 Diabetes","volume":"198","author":"Paun","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.06.007_bib88","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00125-017-4278-3","article-title":"The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities","volume":"60","author":"Brunkwall","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.omtm.2019.06.007_bib89","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1096\/fj.05-5134fje","article-title":"Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system","volume":"20","author":"Limaye","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2019.06.007_bib90","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/HYPERTENSIONAHA.114.03871","article-title":"Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension","volume":"64","author":"Shenoy","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.omtm.2019.06.007_bib91","doi-asserted-by":"crossref","first-page":"36939","DOI":"10.1074\/jbc.M104245200","article-title":"A cholera toxin B-subunit variant that binds ganglioside G(M1) but fails to induce toxicity","volume":"276","author":"Rodighiero","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2019.06.007_bib92","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1073\/pnas.161273098","article-title":"A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity","volume":"98","author":"Aman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.omtm.2019.06.007_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsle\/fnu033","article-title":"High efficiency electrotransformation of Lactobacillus casei","volume":"362","author":"Welker","year":"2015","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.omtm.2019.06.007_bib94","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3923\/jm.2007.727.734","article-title":"Effects of Extraction Methods and Age of Cells on the Whole-cell Protein Patterns of Lactobacillus","volume":"2","author":"Sieo","year":"2007","journal-title":"Research Journal of Microbiology"}],"updated-by":[{"DOI":"10.1016\/j.omtm.2020.02.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000}}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:52:19Z","timestamp":1778867539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":94,"alternative-id":["S2329050119300683"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.06.007","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}